March 8, 2018 / 1:45 PM / in 9 months

BRIEF-Eyegate Pharma Submits Investigational Device Exemption Amendment For Second Pilot Study Of Ocular Bandage Gel

March 8 (Reuters) - Eyegate Pharmaceuticals Inc:

* EYEGATE PHARMA SUBMITS INVESTIGATIONAL DEVICE EXEMPTION AMENDMENT FOR SECOND PILOT STUDY OF OCULAR BANDAGE GEL

* EYEGATE PHARMACEUTICALS - SUBMITTED AMENDED IDE APPLICATION TO U.S. FDA FOR A PILOT STUDY OF EYEGATE OCULAR BANDAGE GEL

* EYEGATE PHARMACEUTICALS INC - AMENDMENT SUMMARIZES CO'S RESPONSES TO FDA'S QUESTIONS AND COMMENTS IN RESPONSE TO ORIGINAL IDE SUBMISSION

* EYEGATE PHARMACEUTICALS INC - AMENDMENT INCLUDES VALIDATION DATA ON MANUFACTURING PROCESSES AND BIOBURDEN TESTS RELATED TO PRODUCTION OF EYEGATE OBG

* EYEGATE PHARMACEUTICALS INC - CONTINUE TO MOVE FORWARD TOWARD PLANNED 510(K) DE NOVO FILING IN 2019 FOR EYEGATE OBG Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below